Milk and Plant Protein Digestion (MAPP-D)

July 26, 2024 updated by: Paul Smeets, Wageningen University

Postprandial Amino Acid Profiles and Gastric Protein Coagulation After Consumption of Milk and Plant-based Alternatives: an Exploratory Study

The goal of this study is to explore the effect of protein quantity and quality in plant-based drinks. Healthy normal-weight males aged between 18 and 45 years will be included in the study.

The main objectives are to examine the differences in postprandial amino acid profiles, and to examine differences in gastric behavior between cow's milk and plant based drinks.

Participants will visit after an overnight fast three times and have blood draws before and after consumption one of the study drinks. There will be MRI scans of the stomach before and after consumption of the drink to assess gastric behavior.

Study Overview

Detailed Description

Rationale: There is a growing interest in plant-based alternatives for bovine milk. However, these plant-based drinks are not a complete nutritional substitute for bovine milk, especially when focusing on the protein content and quality of these products. Knowledge on the effects of protein quantity and quality of plant based drinks on postprandial plasma responses and gastric behavior compared to bovine milk is lacking.

Objective: To explore the effect of protein quantity and quality of protein in plant-based drinks. In addition, gastric behavior will be examined and compared to that of bovine milk.

Study design: Single-blind randomized cross-over study with three treatments.

Study population: 12 healthy normal-weight males, aged 18-45 y.

Intervention: After an overnight fast, participants will drink cow's milk, or a plant-based drink. Gastric behavior will be monitored using Magnetic Resonance Imaging (MRI). Blood samples will be collected for plasma metabolomic analyses. In addition, wellbeing will be assessed.

Study Type

Interventional

Enrollment (Actual)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Wageningen, Netherlands, 6708WE
        • Human Research Unit - Division of Human Nutrition and Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male
  • Age 18 - 45 y
  • Apparently healthy (self-reported)
  • Normal-weight (BMI 18.5 - 25 kg/m2)
  • Willing to be informed about incidental findings of pathology
  • Willing to comply with the study procedures

Exclusion Criteria:

  • Allergy or intolerance for cow milk, lactose or gluten (self-reported)
  • Gastric disorders or regular gastric complaints, for example heart burn
  • Use of medication which alters the normal functioning of the stomach, such as:

    • Medical drug use that influences the GI tract's normal function, e.g. motility, pH etc.: among others use of protein pump inhibitors, antacids, anti-depressants etc. (judged by study doctor)
    • Medical drug use that influences the GI tract's microbiota: antibiotic use within one month prior to the pre-study screening day (judged by study doctor)
  • Following a vegan diet
  • Smoking (>2 cigarettes a week)
  • Having a chronic illness that could affect food digestion and nutrient absorption including but not limited to kidney disease, thyroid disease and diabetes mellitus (self-reported)
  • Alcohol consumption of more than 14 glasses/week
  • Having given a blood donation in the past two months
  • Hb value below 8.5 mmol/L (as measured with finger-prick method at screening)
  • Having a contra-indication to MRI scanning, including, but not limited to:

    • Pacemakers and defibrillators
    • Intraorbital or intraocular metallic fragments
    • Ferromagnetic implants
    • Claustrophobia
  • Participating in other research during the study period
  • Not having a general practitioner

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Low-protein plant-based drink
Ingestion of a low-protein plant-based drink.
Ingestion of a low-protein plant-based drink
Other: High-protein plant-based drink
Ingestion of a high-protein plant-based drink
Ingestion of a high-protein plant-based drink
Other: Cow's milk
Ingestion of cow's milk.
Ingestion of cow's milk

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial plasma amino acid profile as characterized by the peak height and iAUC
Time Frame: 5 hours
Change in postprandial plasma amino acid profile over time
5 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastric behavior
Time Frame: 2 hours
Change in gastric behavior over time as determined from an abdominal MRI scan
2 hours
Postprandial plasma response
Time Frame: 5 hours
Change in postprandial plasma response from baseline over time
5 hours

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Verbal ratings of wellbeing
Time Frame: 5 hours
Change in wellbeing from baseline over time on a 100-point scale
5 hours
MRI markers of digestion
Time Frame: 2 hours
Change in Magnetization Transfer ratio from baseline over time
2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Paul Smeets, PhD, Wageningen University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 6, 2024

Primary Completion (Actual)

July 24, 2024

Study Completion (Actual)

July 24, 2024

Study Registration Dates

First Submitted

February 9, 2024

First Submitted That Met QC Criteria

February 19, 2024

First Posted (Actual)

February 22, 2024

Study Record Updates

Last Update Posted (Actual)

July 29, 2024

Last Update Submitted That Met QC Criteria

July 26, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • NL83162.091.22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Food Digestion

Clinical Trials on Low-protein plant-based drink

Subscribe